secwatch.observer — SEC 8-K summary
======================================

Issuer:     MESA LABORATORIES INC /CO/ (MLAB)
CIK:        0000724004
Form:       8-K
Filed at:   2023-05-25T23:59:59+00:00
Accession:  0001437749-23-015770
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mesa Labs Q4 revenue down 5.6%, AOI down 21%; FY net income down 50% to $0.9M
-----------------------------------------------------------------------------

- Q4 revenues $55.6M, -5.6% YoY; net income $0.6M ($0.11 diluted EPS) vs net loss $1.8M prior year.
- FY23 revenues $219.1M (+18.8%); core organic growth 5.2%; net income $0.9M ($0.17) -50.3% YoY.
- AOI ex-unusual items Q4 $10.7M (-21.1% YoY); FY23 $45.8M (-1.7% YoY).
- Clinical Genomics revenues -15.8% organic; Sema4 closure headwind ~$8.2M annually.
- Management guides conservatively for FY24; sees soft CAPEX orders, expects currency headwinds to abate.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/724004/000143774923015770/0001437749-23-015770-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/724004/000143774923015770/mlab20230524_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-015770

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer